Sugistran 50mg Sunitinib Price USA | Ernest Impex Indian Exporter

Sugistran 50mg Capsule: Precision Multi-Kinase Inhibition for Targeted Oncology Excellence

Are you seeking a reliable Sugistran 50 mg capsule exporter from India? Ernest Impex, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted anti-cancer agents. We facilitate a regulatory-compliant, cold-chain-integrated supply chain serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical oncology therapies are delivered with maximum clinical efficacy.

Detailed Product Overview: What is Sugistran 50 mg?

Sugistran 50mg Capsule is an oral multi-targeted tyrosine kinase inhibitor (TKI) containing the active ingredient Sunitinib. Manufactured by Celon Laboratories Ltd., a pioneer in specialty oncology, Sugistran is engineered to block the specific proteins and enzymes that signal cancer cells to multiply and form new blood vessels.

For international B2B procurement, Sugistran 50mg is a gold-standard choice for treating advanced solid tumors that require powerful, multi-pathway suppression.

Primary Therapeutic Indications

Sugistran 50 mg is clinically utilized globally for:

1. Metastatic Renal Cell Carcinoma (mRCC): A primary treatment for advanced stage kidney cancer.

2. Gastrointestinal Stromal Tumor (GIST): Specifically for rare tumors in the digestive tract that are resistant to or cannot be treated with Imatinib.

3. Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors located in the pancreas.

Mechanism of Action: Multi-Pathway Signal Inhibition

Sugistran 50mg operates through a sophisticated dual-action process that targets both tumor growth and the tumor's life-support system:

• Receptor Blockade: It inhibits multiple receptor tyrosine kinases (RTKs), specifically targeting vascular endothelial growth factor receptors (VEGFR-1, -2, -3) and platelet-derived growth factor receptors (PDGFR-α, -β).

• Anti-Angiogenesis: By blocking the VEGFR pathway, Sugistran prevents the tumor from developing the new blood vessels it needs to "feed" its growth.

• Direct Growth Arrest: It targets KIT and FLT3 receptors, which are vital for the uncontrolled division of cancer cells in gastrointestinal and hematological malignancies.

• Systemic Starvation: This combined action starves the tumor of nutrients while simultaneously halting the internal signals for cell division.

Administration and Clinical Safety

• Dosage Schedule: Typically taken once daily. For GIST and RCC, the standard protocol is often 4 weeks on treatment followed by a 2-week break.

• Storage: Store at room temperature (below 30°C) in a dry place. Keep the container tightly closed to protect from light.

• Key Clinical Monitoring:

  • Blood Pressure: Hypertension is a common side effect; regular monitoring is mandatory.

  • Thyroid Function: Routine checks for hypothyroidism are standard during Sunitinib therapy.

  • Liver & Cardiac Health: Periodic liver function tests (LFTs) and cardiovascular assessments (LVEF) are recommended.

  • Blood Sugar: Diabetics should monitor blood glucose levels closely, as Sugistran can cause hypoglycemia.

Why Source Sugistran from Ernest Impex?

• Authentic Celon Oncology Exporter: Direct access to genuine Celon Laboratories inventory, ensuring 100% product authenticity and competitive bulk pricing.

• Specialized Logistics Authority: We specialize in the complex documentation and cold-chain logistics required for Washington, London, Bangkok, Canberra, Singapore, and Kingston.

• Regulatory Transparency: We provide all essential B2B documentation, including GMP compliance, batch-specific COAs, and necessary export permits.

• Bulk Supply Stability: We specialize in large-scale fulfillment for hospital pharmacies, specialty oncology centers, and regional distributors.